MONETA GROUP INVESTMENT ADVISORS LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1120927
ST LOUIS, MO
Position in REGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$313,017
-$56,304 QoQ
Shares Held
502
+5.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#928
of 1,322 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $3,273,847 across 13 Biotechnology names. REGN ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADAG |
Adagene Inc.
|
200,000 | $840,000 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
895 | $444,573 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
4,715 | $409,969 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
502 | $313,017 | |
| 5 | CAI |
Caris Life Sciences, Inc.
|
17,159 | $305,773 | |
| 6 | ONC |
BeOne Medicines Ltd.
|
815 | $232,250 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
9,399 | $226,327 | |
| 8 | CADL |
Candel Therapeutics, Inc.
|
14,525 | $149,607 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $313,017 | 502 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $369,321 | 478 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $329,588 | 427 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $249,085 | 443 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $236,250 | 450 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $501,041 | 790 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $534,959 | 751 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $901,963 | 858 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $879,712 | 837 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $652,568 | 678 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $499,747 | 569 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $469,910 | 571 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $412,441 | 574 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $528,333 | 643 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $372,288 | 516 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $692,314 | 1,005 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $595,267 | 1,007 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $386,924 | 554 | Shares | Sole | 2022-05-11 | |
| No filing history on record for this holder in this stock. | ||||||